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Cardiovascular disease is estimated to be the leading cause 
of death, globally causing 14 million deaths each year. 
Stroke remains a massive public health problem and there 
is an increasing need for better strategies for the preven-
tion and treatment of this disease. At least 20% of ischemic 
strokes are thromboembolic in nature, caused by a throm-
boembolism from an atherosclerotic plaque at the carotid 
bifurcation or the internal carotid artery. Current clinical 
guidelines for both primary and secondary prevention of 
stroke in patients with carotid stenosis caused by athero-
sclerotic plaques remain reliant on general patient charac-
teristics (traditional risk factors for stroke) and static meas-
ures of the degree of artery stenosis. Patients with similar 
traditional risk factors, however, have been found to have 
different risk of stroke, and it has in recent years become 
increasingly clear that the degree of artery stenosis alone 
is not the best estimation of stroke risk. There is a need for 
new methods for the assessment of stroke risk to improve 
risk prediction for the individual patient. This review aims 
to give an overview of new methods available for the iden-
tification of carotid plaque instability and the assessment 
of stroke risk.
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Cardiovascular disease (CVD) is estimated to be the lead-
ing cause of death globally, causing 14 million deaths 
each year (1). It is also the leading cause of long-term 
disability in older adults, and consequently a substantial 
contributor to health care costs. Stroke remains a mas-
sive public health problem and there is an increasing 
need for better strategies for the prevention and treat-
ment of this disease. At least 20% of ischemic strokes are 
thromboembolic in nature (2), caused by a thromboem-
bolism from an atherosclerotic plaque at the carotid bi-
furcation or the internal carotid artery. Such strokes have 
been shown to be preventable by surgical removal of 
the plaque with carotid endarterectomy (CEA) or stent-
ing (3,4).
Current clinical guidelines for both primary and second-
ary prevention of stroke in patients with carotid stenosis 
caused by atherosclerotic plaques remain reliant on gen-
eral patient characteristics (traditional risk factors; hyper-
tension, smoking, diabetes, and hypercholesterolemia) 
and static measures of the degree of artery stenosis (5). 
Patients with similar traditional risk factors, however, have 
been found to have different risk of stroke (6), and it has 
in recent years become increasingly clear that the degree 
of artery stenosis alone is not the best estimation of stroke 
risk. There is a need for new methods for the assessment 
of stroke risk to improve risk prediction for the individu-
al patient. Research has shown that the properties of the 
plaque itself are important for its stability and the risk of 
stroke, and that inflammation plays an important patho-
genic role in all stages of plaque development, including 
rupture (7-9). There has therefore, over the last decade, 
been a paradigm shift in the image-based risk stratifica-
tion of carotid disease from the static measurement of ca-
rotid artery stenosis to the characterization of the dynam-
ic biological processes occurring within carotid plaques. 
The focus of atherosclerosis research has also broadened 
to include not only the study of a single atherosclerotic 
carotid plaque, but also the identification and assessment 
of generalized inflammation as well as the association be-
tween systemic inflammation and cardiovascular risk.
The most recent revision of the American College of Car-
diology/American Heart Association (AHA) Task Force on 
Practice Guidelines continued the emphasis on the use 
cholesterol level-lowering drugs to reduce cardiovascu-
lar risk based on epidemiologically defined traditional risk 
factors (10). However, this 2013 task force acknowledged 
that other treatment approaches, including the use of 
carotid plaque burden features to determine individ-
ual risk and modify treatment therapy may be important, 
but are not yet evaluated in randomized clinical trials.
The limitations of current clinical guidelines for primary 
and secondary prevention of stroke for patients with ca-
rotid artery stenosis become particularly evident with ref-
erence to two clinical patient groups:
(i) Patients with asymptomatic carotid artery stenosis: 
where the identification and treatment of risk factors re-
mains the hallmark of risk assessment and treatment. How-
ever, despite optimal medical management aimed at iden-
tifiable risk factors, patients with asymptomatic carotid 
stenosis develop an ischemic stroke. The Asymptomatic 
Carotid Stenosis and Risk of Stroke Trial (ACSRS) is a large 
prospective study on patients with asymptomatic carotid 
stenosis (ACS) undergoing medical intervention (6). ACSRS 
has shown that not all patients with ACS carry the same 
risk of stroke. Specifically the severity of carotid stenosis, a 
history of contralateral transient ischemic attack (TIA), and 
several carotid plaque features on ultrasonography could 
stratify patients into groups of varying annual stroke risk 
from less than 1% to greater than 10%. There are two on-
going large randomized clinical trials evaluating medical 
therapy vs surgical/endovascular intervention in patients 
with ACS (Carotid Revascularization Endarterectomy vs 
Stenting Trial [CREST-2] (11) and Asymptomatic Carotid 
Surgery Trial [ACST-2]) (12). Both will include an imaging 
sub-study to evaluate the role of vulnerable plaque imag-
ing in asymptomatic patients with greater than 70% carot-
id stenosis.
(ii) Patients with symptomatic stenosis causing mild-mod-
erate carotid artery stenosis where clinical guidelines are 
based on studies more than 15 years old (NASCET 1999, 
ESCT 1998) (3,4) in which the degree of stenosis was used 
to predict stroke risk and also the main criteria for selecting 
patients for surgical removal of plaque.
This review will focus on new methods available for the 
identification of carotid plaque instability and the assess-
ment of stroke risk.
The paThophySiology of aTheRoScleRoSiS
Atherosclerotic lesions develop slowly over many years, 
passing through several stages. Risk factors for atheroscle-
rosis such as hypertension, diabetes, smoking, hypercho-
lesterolemia, genetic disposition, infection, and elevated 
homocysteine can activate pro-inflammatory and anti-
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thrombotic responses that induce endothelial dysfunc-
tion (13). Inflammation and oxidative stress mediate these 
risk factors, especially oxidized low-density lipoprotein (ox-
LDL, due to hypercholesterolemia), which can activate the 
endothelium, leading to increased permeability and en-
dothelial dysfunction (13). These dysfunctional endothe-
lial cells then express adhesion molecules (vascular cell 
adhesion molecule-1, VCAM-1, and p-selectin) allowing 
the adherence of monocytes, T-lymphocytes, and plate-
lets to the endothelium, which then become pro-inflam-
matory and pro-thrombotic (14). Monocytes are recruited 
into the intima (by monocyte chemo attractant protein-1, 
MCP-1) and differentiate into macrophages in response to 
macrophage colony-stimulating factors (M-CSF) and other 
pro-inflammatory mediators. Macrophages ingest ox-LDL 
by receptor-mediated phagocytosis, which promotes the 
transformation of macrophages into lipid-laden foam cells 
leading to retention of LDL particles and immune cells in 
the intimal layer of the vessel wall. This accumulation of 
lipids and associated immune cells, the “fatty streaks,” are 
asymptomatic and non-stenotic, and are histologically the 
earliest sign of atherosclerosis. Macrophages and other im-
mune cells release cytokines, chemokines, and growth fac-
tors, which mediate further leukocyte recruitment leading 
to further inflammation and over time the development 
of an atherosclerotic plaque. Proliferation and migration 
of smooth muscle cells (SMCs) from the adventitia to in-
tima lead to the development of the fibrous cap, which 
surrounds the atherosclerotic lesion. In addition to SMCs, 
the fibrous cap consists of connective tissue, such as col-
lagen, which may be weakened by matrix metalloprotei-
nases (MMPs). The atherosclerotic process progresses with 
apoptosis of the SMCs and macrophages mainly regulated 
by cytotoxic T-cells, leading to the formation of a lipid-rich 
necrotic core and increased plaque instability.
As the plaque core becomes necrotic it contains increas-
ing amounts of cellular debris, crystalline cholesterol, and 
inflammatory cells, especially macrophage foam cells. The 
necrotic core becomes covered by the fibrous cap, which 
also contains inflammatory cells mainly in the “shoulder” 
region (the portion of the plaque lateral to the lipid core), 
where T-cells, mast cells, and especially macrophages have 
a tendency to accumulate (15,16). Advanced plaque le-
sions become increasingly complex with calcification, new 
vessel formation, thinning of the fibrous cap, and eventu-
ally plaque rupture. The strength of the fibrous cap, which 
is very important for plaque stability, is determined by 
the activity of the different pro-inflammatory and anti-in-
flammatory cytokines/mediators within the plaque. This 
determines the balance between production (transform-
ing growth factor-β [TGF-β]) and breakdown (MMPs and 
interferon-γ [IFN-γ]) of collagen.
In the event of plaque rupture, the plaque content includ-
ing the thrombogenic lipid core is exposed to blood con-
taining platelets and coagulation factors with a resultant 
high risk of thrombus formation. Cerebrovascular symp-
toms are the result of these thrombi causing vessel occlu-
sion at the plaque location and/or emboli that are carried 
in the blood stream to the brain where they occlude cere-
bral blood vessels.
The UNSTaBle caRoTiD plaQUe, iNflaMMaTioN, 
aND feaTUReS of plaQUe iNSTaBiliTy
Traditionally, atherosclerosis has been viewed as a slowly 
progressive, cholesterol storage disease involving the pas-
sive accumulation of cholesterol debris in the arterial wall. 
However, atherosclerosis is now accepted as a generalized 
inflammatory disease. In fact, inflammation plays an impor-
tant pathogenic role in all stages of atherosclerosis includ-
ing the destabilization of atherosclerotic plaques (7-9). His-
tological features associated with this destabilization and 
plaque instability are a large lipid rich necrotic core (LRNC), 
intra plaque hemorrhage (IPH), and thinning of the fibrous 
cap (FC) (17-19). Stable plaques in contrast are characteris-
tically more calcified with a thicker fibrous cap.
UlTRaSoUND iMagiNg
Carotid ultrasonography allows the measurement of inti-
ma-media thickness (IMT), detection of plaque, descrip-
tion of plaque morphology, and estimation of luminal 
stenosis, and assessment of plaque echogenicity (20,21). 
Plaque echogenicity, total plaque area, and plaque surface 
irregularities have all been suggested as ultrasound mark-
ers of unstable plaques and increased stroke risk (22-25). 
Total plaque area has been shown to be a more sensitive 
and reliable measure of atherosclerotic burden than IMT 
and plaque (26).
iNTiMa MeDia ThicKNeSS (iMT)
IMT is the measurement of the thickness of tunica intima 
and tunica media, the innermost two layers of the wall of 
an artery made by carotid ultrasound. Increased carotid 
IMT in patients over the age of 50 has been shown to be 
predictive of future cardiovascular events (27). Howev-
er, the clinical usefulness of measuring the progres-
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sion or potential decrease in the IMT as a surrogate end-
point to assess drug efficacy in clinical trials or in clinical 
management in cardiovascular disease is unclear. This is 
because the annual change in carotid IMT often estimated 
to be from 0.01 to 0.04 mm in health and disease is lower 
than the current-generation ultrasound pixel resolution of 
0.1 to 0.2 mm, making it very difficult to follow carotid IMT 
change in individual patients short term (28-31).
plaQUe echogeNiciTy
The level of plaque echogenicity reflects plaque content 
(32,33). Although the association between echolucent 
plaques, plaque instability, and cerebrovascular events is 
not fully understood, there is a probable association be-
tween echolucency and inflammatory burden, with mac-
rophages contributing to plaque destabilization in echolu-
cent lesions (34,35). Echolucent carotid artery plaques (rich 
in lipids and/or intraplaque hemorrhage) are associated 
with increased risk of stroke, independent of the degree of 
artery stenosis (36,37) (Figure 1).
plaQUe NeovaScUlaRiZaTioN
New vessel formation (neovascularization) is associated with 
plaque instability and vessel hypoxia (38,39). These vessels 
have low-velocity blood flow, which in conventional Dop-
pler imaging is filtered out by a wall filter to remove clut-
ter and motion artifacts, resulting in a loss of this low-flow 
component. Therefore, the limitation for conventional Dop-
pler imaging to detect microvascularity makes the evalua-
tion of intra-plaque neovascularization very challenging.
contrast enhanced ultrasound (ceUS)
CEUS has emerged as valuable ultrasound imaging mo-
dality that compliments and enhances standard ul-
trasound imaging mainly by providing an improved visual-
ization of delineation of the vascular wall (the fibrous cap). 
Moreover, CEUS has been shown to reliably evaluate intra-
plaque neovascularization and identify carotid artery ulcer-
ation with superior diagnostic accuracy compared to the col-
or Doppler techniques (40,41). Ultrasound contrast agents 
are sulforhexafluoride gas filled microbubbles measuring 
approximately 1-8 µm, which are injected intravenously and 
serve as intravascular tracers. These microbubbles contrast 
agents are stable, strong reflectors and resonators when 
exposed to an ultrasound beam. Contrast enhancement is 
usually graded on a 4-point scale. So far, quantification of 
contrast uptake within a plaque remains challenging, and 
methods for quantification are still under development. Sev-
eral studies have demonstrated a good correlation of neo-
vascularization detected by CEUS with microvessel density 
assessed by histological examination (40,42,43).
Superb microvascular imaging (SMi)
SMI is a Doppler technology that allows the visualization 
of minute vessels with low flow signals without the use of 
contrast agents. SMI effectively separates flow signals from 
overlying tissue motion artifacts, preserving low-flow com-
ponent (44).
plaQUe aND aRTeRy STiffNeSS
Shear wave elastography (SWe)
SWE is an emerging ultrasound method, which exploits 
acoustic radiation forces to generate shear wave propaga-
tion in tissue. Recent research suggests that plaques rup-
ture when the peak stress within the fibrous cap exceeds 
a certain threshold level (45). Knowledge about the stress 
distribution within the fibrous cap may therefore predict 
the risk of plaque rupture. A recent study by Garrard dem-
onstrated that SWE was able to identify features of plaque 
vulnerability, and provide additional information related to 
plaque tissue characteristics (46). SWE enables the assess-
ment of tissue stiffness by quantifying the Young’s modu-
lus of elasticity.
Transcranial Doppler
Transcranial Doppler monitors cerebral blood flow and can 
detect microembolic signals (MES) from the blood stream 
representing thromboemboli. Two large prospective stud-
ies showed that MES on transcranial Doppler (TCD) iden-
tified high-risk patients with ACS, and that patients with 
figURe 1. carotid ultrasound showing echolucent plaques. 
plaque in the far wall of the common carotid artery (arrow 
pointing down) and in the near wall at the carotid bifurcation 
(arrow pointing up).
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asymptomatic carotid stenosis and MES had a stroke risk 
comparable to symptomatic patients with high-grade 
stenosis (47).
computed tomography (cT)
The presence of clinically silent infarcts on CT brain imag-
ing in patients with moderate to severe carotid stenosis 
(60%-79%) was in the ACSRS study found to be associated 
with an increased risk of stroke (48). CT brain imaging can 
therefore be of value in the risk assessment of asymptom-
atic carotid stenosis.
computed angiography (cTa)
CT angiography (CTA) is used in clinical practice for the as-
sessment of plaque and degree of artery stenosis. Studies 
have found that the overall agreement on the estimation 
of the degree of artery stenosis between carotid Doppler 
ultrasound and CTA is good at 79.1% (95% confidence in-
terval 0.72-0.83). However, CTA is unable to reliably dis-
tinguish between moderate (50%-69%) and severe (70%-
99%) stenosis, which is important for clinical management 
and a limitation of this investigation. CT angiography, how-
ever, cannot accurately measure plaque volume (because 
remodeling can accommodate large plaques with little im-
pact on lumen diameter) (49).
MagNeTic ReSoNaNce iMagiNg (MRi)
carotid MRi
Recent developments in MRI technology have shown 
promise allowing the identification high-risk carotid 
plaque characteristics (large LRNC, IPH, TRFC/ulceration) 
and the accurate discrimination between the specific his-
tological subtypes of carotid plaques as proposed by the 
American Heart Association (50). Multiple single-center 
prospective trials have shown the ability of these multi-
ple MR-defined plaque characteristics, such as the size of 
the LRNC, IPH, and TRFC to stratify risk of future carotid 
TIA or stroke (51,52). These high-risk plaque characteris-
tics such as a large LRNC may represent a phenotype of 
asymptomatic carotid artery stenosis with high risk of fu-
ture events that may be amenable to intensive medical 
therapy. IPH and ruptured FC/ulceration may represent 
vulnerable plaque that requires close monitoring to iden-
tify plaque progression or new symptoms despite inten-
sive medical therapy and in some cases may require sur-
gical intervention.
Gupta et al (51) in a systematic review that included 9 MRI 
studies with 779 participants found that carotid plaques 
with LRNC, IPH, and a thin, ruptured fibrous cap identified 
on MRI were significantly more likely to result in ipsilateral 
ischemic events. Four of the 7 studies examined more than 
one plaque element, but a multiparametric testing ap-
proach addressing the significance of each plaque compo-
nent was not performed in any of the studies. The authors 
concluded that MRI characterization of specific plaque 
elements (LRNC, IPH, and TRFC) could provide additional 
measures of stroke risk not provided by simple measure-
ments of luminal stenosis (51).
The majority of current imaging studies of atherosclerotic 
plaques rely on a human observer´s interpretation of the 
MRI findings with different contrast weighting, producing 
measurements that have been compared with histological 
assessments. This manual plaque segmentation requires 
expertise, is time consuming, and produces results that are 
subject to interobserver variability (53). Contrast enhanced 
automated classification may provide more objective and 
reliable assessments of plaque composition. Klooster et al 
(54) imaged 40 patients who had carotid plaques with MRI 
and found good agreement between automatic and visual 
identification of plaque components. They found that the 
volumes of hemorrhage and lipids assessed by visual and 
automatic assessments were reasonably consistent but not 
for calcium. In a further study semi-automated MRI assess-
ments of the percentage of LRNC in carotid plaques were 
found to be significantly correlated with the percentage 
LRNC on histological assessment, and to echolucency on 
ultrasound, with echolucent plaques having larger LRCN 
compared to echogenic plaques (55).
MRI of plaque composition is a relatively new technique 
and studies have shown a high diversity in findings us-
ing different MRI protocols and different techniques in the 
histological assessments (51,56). It is therefore difficult to 
draw definite conclusions regarding the value of carotid 
plaque MRI characterization. In addition, patients are of-
ten included in the studies after a long time interval from 
symptom onset, and the possibility that the plaque com-
ponents may change over time was therefore not taken 
into account.
Brain MRi
Moderate and severe internal carotid stenosis has been 
associated with higher prevalence of clinically silent 
cerebral infarcts on brain MRI and this investigation 
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may therefore aid risk assessment for patients with asymp-
tomatic carotid stenosis (57).
MolecUlaR iMagiNg
In recent years there has been growing interest in the ability 
of positron emission tomography (PET) to assess plaque in-
flammatory content. Due to the infiltration and retention of 
oxidized lipids in the arterial wall, vulnerable plaques con-
tain a greater density of macrophages compared to asymp-
tomatic plaques (58). Activated macrophages have a sig-
nificantly increased metabolic rate and therefore increased 
2-deoxy-2- [18F] fluoro-D-glucose (18F-FDG) uptake. Rudd et 
al (59) found increased 18F-FDG in macrophage-rich regions 
of carotid plaques, removed at endarterectomy, in 8 symp-
tomatic patients compared to contralateral asymptomatic 
plaques in the same patients. Tawakol et al (60) demonstrat-
ed that in vivo 18F-FDG uptake correlated with the degree 
of carotid plaque inflammation in 17 patients when mac-
rophage staining was assessed histologically.
18F-FDG uptake has also been shown to correlate with oth-
er factors that are associated with plaque instability. Carotid 
plaques with decreased ultrasound echogenicity and pa-
tients with increased serum lipids have been found to have 
higher degree of 18F-FDG uptake on PET (61-63). Evidence 
from longitudinal studies also suggests that arterial 18F-
FDG uptake may be related to patient outcome. Figueroa 
et al (64) followed 513 patients without symptomatic car-
diovascular disease for a mean of 4.2 years. They found that 
18F-FDG uptake in the wall of the ascending aorta was an 
independent predictor of future cardiovascular events. Re-
sults from the Dublin Carotid Atherosclerosis Stroke Study 
showed, in 67 patients with a recent ischemic event (TIA 
or stroke), that carotid plaque inflammation, measured by 
18F-FDG PET, was associated with a high risk of early stroke 
recurrence, independent of the degree of stenosis (65).
These studies have, however, been limited by relatively 
small sample sizes and time delays of weeks or months 
from symptoms to 18F-FDG PET imaging and histology fol-
lowing endarterectomy. There is therefore a possibility that 
plaque inflammation may have been modified by medica-
tions and life-style changes during these time-delays from 
symptoms to imaging and histological assessments. In-
creased 18F-FDG uptake must be closely correlated in time 
to ipsilateral ischemic cerebral events and be higher in 
symptomatic compared to asymptomatic patients if this 
method is to be of value in the clinical management 
of patients.
Combined MRI and PET can be expected to have an ad-
ditional value over PET/CT in non-invasive imaging of ath-
erosclerosis since CT does not visualize the vessel wall 
but primarily the lumen. Despite the limited spatial reso-
lution of PET, CT can give the anatomical localization of 
the 18F-FDG signal with regard to individual atheroscle-
rotic lesions. CT angiography, however, cannot accurately 
measure plaque volume because remodeling can accom-
modate large plaques with little impact on lumen diam-
eter. A whole-body PET/MR imager allowing simultaneous 
MR and PET imaging has therefore been developed. The 
main advantage of this method is the perfect alignment 
between PET and MRI that allows for a precise delineation 
of the vessel wall, or plaque, and characterization of plaque 
components (eg, the necrotic core). In addition, it requires 
less examination time compared to sequential MRI and 
PET. In comparison with PET/CT the advantages of MRI are 
decreased radiation and superior visualization of soft-tis-
sue plaque components.
Improvements in new-generation PET scanners are be-
lieved to provide better resolution and thereby better im-
aging of small structures such as carotid plaques. The use 
of macrophage specific tracers, 64-CU DOTATAE, 11-C-
PK11195, are being evaluated with the hope of improving 
the plaque/background ratio of glucose (66). In addition 
to improving the assessment of inflammation in carotid 
plaques, these tracers may eventually allow the imaging 
of atherosclerosis in arteries where background uptake of 
18 F-FDG would be prohibitively high, such as those in the 
cerebral and coronary circulation.
BioMaRKeRS of plaQUe iNSTaBiliTy
In addition to CRP many different inflammatory mediators 
involved in the atherosclerotic process have been mea-
sured in plasma and found to be associated with plaque in-
stability (fibrinogen, leukocytes MMP-7, IL23, visfatin gran-
zyme B CD-36 IL-6 VCAM-1). However, thus far no single 
biomarker has been found able to reliably predict ischemic 
stroke or CVD (67-74).
coNclUSioN
Carotid plaque assessment with carotid ultrasonography 
and MR imaging provides superior risk stratification for 
individual patients compared with carotid stenosis and 
other epidemiologically identified cardiovascular risk fac-
tors. New methods in ultrasonography and molecular im-
aging can provide new information on plaque pathology 
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and have the potential to aid in cerebrovascular risk assess-
ment. Application of plaque imaging in prospective stud-
ies and multicenter trials in patients with asymptomatic 
and symptomatic carotid artery stenosis will hopefully, in 
the near future, tell us how we can best guide treatment 
on an individual patient level.
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